Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Navigating the atopic dermatitis toolbox: Challenging scenarios and shared decision-making.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology - 1 Mar 2024

Samynathan Archana, Silverberg Jonathan I

Abstract excerpt

Atopic dermatitis (AD) is a chronic inflammatory disease with a complex pathogenesis and heterogeneous clinical presentation. Recently, multiple advanced therapies were approved for the treatment of moderate-severe AD, including the biologics dupilumab, tralokinumab, and lebrikizumab and oral Janus kinase inhibitors abrocitinib, upadacitinib, and baricitinib. These treatments have different efficacy, safety, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dermatitis, Atopic
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Health Personnel

Source

Identifiers

PMID: 38145707
DOI: 10.1016/j.anai.2023.12.020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Navigating the atopic dermatitis toolbox: Challenging scenarios and shared decision-making.PMID 38145707Read ↗

Deciphering atopic dermatitis heterogeneity: a short review on the translational revolution from endotypes to immunotypes.Semantic proximity Read ↗

[The status and prospects of studies about atopic dermatitis].Semantic proximity Read ↗

Efficacy Trajectory and Hematologic Safety of Oral JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Prospective Real-World StudySemantic proximity Read ↗

The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment.Semantic proximity Read ↗

Current updates in the epidemiology and comorbidities of atopic dermatitis.Semantic proximity Read ↗

Atopic dermatitis.Semantic proximity Read ↗

Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?Semantic proximity Read ↗

New pathogenic and therapeutic paradigms in atopic dermatitis.Semantic proximity Read ↗

Defining and Measuring the Scope of Atopic Dermatitis.Semantic proximity Read ↗

Management of Atopic Hand Dermatitis.Semantic proximity Read ↗

Atopic Dermatitis Beyond the Skin Barrier: Precision Medicine Approaches to Immunological Profiling and Therapeutic InnovationSemantic proximity Read ↗

Update on the pathogenesis of atopic dermatitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.